|
Exploration of tumor genetic alterations and associations with clinical outcomes: Retrospective genomic analysis of archived liposarcoma (LPS) and leiomyosarcoma (LMS) samples from phase III trial of trabectedin (T) versus dacarbazine (D). |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
|
|
No Relationships to Disclose |
|
|
Employment - Johnson & Johnson |
Stock and Other Ownership Interests - Johnson & Johnson; Johnson & Johnson (I) |
Travel, Accommodations, Expenses - Johnson & Johnson |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
Patents, Royalties, Other Intellectual Property - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Honoraria - Lilly; Springer; Wiley |
Consulting or Advisory Role - AADi; American Board of Internal Medicine (ABIM); Arcus Ventures; Bayer; Deciphera; Foundation Medicine; Janssen Scientific Affairs; Karyopharm Therapeutics; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma |
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); FORMA Therapeutics (Inst); Immunocore (Inst); Lilly (Inst); Pfizer (Inst); Presage Biosciences (Inst); Regeneron (Inst); TRACON Pharma (Inst); Xencor (Inst) |
Patents, Royalties, Other Intellectual Property - Springer and Wiley: Books for contributions I have made to the published texts; Uptodate: I write and edit chapters for their online text book. |
Travel, Accommodations, Expenses - Bayer; TRACON Pharma |
|
|
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; deciphera; Janssen Oncology |
Research Funding - ArQule |
Travel, Accommodations, Expenses - Arog |
Other Relationship - NCCN |
|
|
Consulting or Advisory Role - Bayer; Bayer; CytRx Corporation; CytRx Corporation; Eisai; EMD Serono; Epizyme; Epizyme; Janssen; Lilly; Lilly; Morphotek; Novartis; Novartis |
Research Funding - Eisai (Inst); Janssen (Inst); Morphotek (Inst) |
|
|
No Relationships to Disclose |